DVT Management and Outcome Trends, 2001 to 2014.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Accès restreint UNIL
Etat: Public
Version: de l'auteur⸱e
Licence: Non spécifiée
ID Serval
serval:BIB_5AD28A85934A
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
DVT Management and Outcome Trends, 2001 to 2014.
Périodique
Chest
Auteur⸱e⸱s
Morillo R., Jiménez D., Aibar M.Á., Mastroiacovo D., Wells P.S., Sampériz Á., Saraiva de Sousa M., Muriel A., Yusen R.D., Monreal M.
Collaborateur⸱rice⸱s
RIETE investigators
Contributeur⸱rice⸱s
Monreal M., Decousus H., Prandoni P., Brenner B., Barba R., Di Micco P., Bertoletti L., Schellong S., Tzoran I., Reis A., Bosevski M., Bounameaux H., Malý R., Wells P., Papadakis M., Agudo P., Aibar M.A., Akasbi M., Alcalde-Manero M., Andújar V., Arcelus J.I., Ballaz A., Barba R., Barrón M., Barrón-Andrés B., Bascuñana J., Blanco-Molina A., Cañas I., Casado I., de Miguel J., Del Toro J., Díaz S., Díaz-Peromingo J.A., Falgá C., Fernández-Capitán C., Font C., Font L., Gallego P., García-Bragado F., García-Rodenas M., Gómez V., González C.J., Grau E., Guirado L., Gutiérrez J., Hernández G., Hernández-Blasco L., Isern V., Jara-Palomares L., Jaras M.J., Jiménez D., Lobo J.L., López-Jiménez L., López-Reyes R., López-Sáez J.B., Lorente M.A., Lorenzo A., Madridano O., Maestre A., Marchena P.J., Martín M., Martín-Antorán J.M., Martín-Martos F., Monreal M., Morales M.V., Nauffal D., Nieto J.A., Nieto S., Núñez M.J., Orbegoso C., Otalora S., Otero R., Pagán B., Pedrajas J.M., Pérez C., Pérez G., Peris M.L., Pons I., Porras J.A., Reig O., Riera-Mestre A., Rivas A., Rodríguez C., Rodríguez-Dávila M.A., Rosa V., Rosa-Murillo A.S., Ruiz-Giménez N., Sahuquillo J.C., Sala M.C., Sampériz A., Sánchez R., Sanz O., Soler S., Suriñach J.M., Tolosa C., Trujillo-Santos J., Uresandi F., Valero B., Valle R., Vela J., Vidal G., Vilar C., Villalta J., Xifre B., Vanassche T., Verhamme P., Wells P., Hirmerova J., Malý R., Tomko T., Celis G., Salgado E., Sánchez G.T., Bertoletti L., Bura-Riviere A., Farge-Bancel D., Hij A., Mahé I., Merah A., Quere I., Papadakis M., Braester A., Brenner B., Tzoran I., Apollonio A., Barillari G., Bertone A., Bilora F., Bucherini E., Ciammaichella M., De Ciantis P., Dentali F., Di Micco P., Duce R., Ferrazzi P., Grandone E., Lessiani G., Lodigiani C., Mastroiacovo D., Pace F., Pesavento R., Pinelli M., Poggio R., Prandoni P., Rosa M., Rota L., Tiraferri E., Tonello D., Tufano A., Venturelli U., Visonà A., Zalunardo B., Drucka E., Kigitovica D., Skride A., Mafalda A., Ribeiro J.L., Sousa M.S., Bosevski M., Zdraveska M., Bounameaux H., Mazzolai L.
ISSN
1931-3543 (Electronic)
ISSN-L
0012-3692
Statut éditorial
Publié
Date de publication
08/2016
Peer-reviewed
Oui
Volume
150
Numéro
2
Pages
374-383
Langue
anglais
Notes
Publication types: Journal Article ; Observational Study
Publication Status: ppublish
Résumé
A comprehensive evaluation of temporal trends in the treatment of patients who have DVT may assist with identification of modifiable factors that contribute to short-term outcomes.
We assessed temporal trends in length of hospital stay and use of pharmacological and interventional therapies among 26,695 adults with DVT enrolled in the Registro Informatizado de la Enfermedad TromboEmbólica registry between 2001 and 2014. We also examined temporal trends in risk-adjusted rates of all-cause, pulmonary embolism-related, and bleeding-related death to 30 days after diagnosis.
The mean length of hospital stay decreased from 9.0 days in 2001 to 2005 to 7.6 days in 2010 to 2014 (P < .01). For initial DVT treatment, the use of low-molecular-weight heparin decreased from 98% to 90% (P < .01). Direct oral anticoagulants use increased from 0.5% in 2010 to 13.4% in 2014 (P < .001). Risk-adjusted rates of 30-day all-cause mortality decreased from 3.9% in 2001 to 2005 to 2.7% in 2010 to 2014 (adjusted rate ratio per year, 0.84; 95% CI, 0.74-0.96; P < .01). VTE-related mortality showed a nonstatistically significant downward trend (adjusted rate ratio per year, 0.70; 95% CI, 0.44-1.10; P = .13), whereas 30-day bleeding-related mortality significantly decreased from 0.5% in 2001 to 2005 to 0.1% in 2010-2014 (adjusted rate ratio per year, 0.55; 95% CI, 0.40-0.77; P < .01).
This international registry-based temporal analysis identified reductions in length of stay for adults hospitalized for DVT. The study also found a decreasing trend in adjusted rates of all-cause and bleeding-related mortality.
Mots-clé
Adult, Aged, Aged, 80 and over, Anticoagulants/therapeutic use, Cause of Death, Cohort Studies, Disease Management, Female, Hemorrhage/chemically induced, Heparin, Low-Molecular-Weight/therapeutic use, Humans, Length of Stay/trends, Male, Middle Aged, Mortality/trends, Population Growth, Prognosis, Registries, Retrospective Studies, Thrombolytic Therapy/statistics & numerical data, Thrombolytic Therapy/trends, Vena Cava Filters/statistics & numerical data, Vena Cava Filters/trends, Venous Thrombosis/mortality, Venous Thrombosis/therapy, DVT, prognosis, survival
Pubmed
Web of science
Création de la notice
26/11/2020 11:00
Dernière modification de la notice
18/02/2021 6:29
Données d'usage